The 3rd Annual Oncology Biomarkers Congress 2013 is dedicated to key insights into companion diagnostics, biomarkers, safety, personalized medicine, decision making and translational medicine in oncology.
The 3rd Annual Oncology Biomarkers Congress 2013 brings together senior level attendees from leading biopharmaceutical, pharmaceutical, diagnostics, biotechnology, government, academics, solution provider companies and CRO involved in Clinical Pharmacology, Biomarkers, Metabolomics, Discovery, Safety, Genomics, Statistical Biomarkers, Pharmacogenomics, R&D, Clinical Research, MicroRNA, Pharmacogenetics, Clinical Oncology, Oncology, Toxicity, Translational Research, Imaging, Molecular Informatics, Proteomics, Molecular Biology, Regulation, Experimental Medicine, Diagnostics, Clinical Discovery, Discovery Medicine, Epigenetics, PK/PD and Systems Biology.
